Evidence map›Paper›PMID 31891781›Full record

ArticleBiochimica et biophysica acta. Gene regulatory mechanisms2020

G-quadruplex deconvolution with physiological mimicry enhances primary screening: Optimizing the FRET Melt

Rhianna K Morgan, Alexandra Maria Psaras, Quinea Lassiter, Kelsey Raymer, Tracy A Brooks

Open access · greenAbstract read
In one paragraph

Article in Biochimica et biophysica acta. Gene regulatory mechanisms, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Rhianna K MorganSchool of Veterinary Medicine, Department of Molecular Biosciences, University of California-Davis, Davis, CA 95616, United States of America; School of Pharmacy, Department of BioMolecular Sciences, University of Mississippi, MS 38677, United States of America.
Alexandra Maria PsarasSchool of Pharmacy and Pharmaceutical Sciences, Department of Pharmaceutical Sciences, Binghamton University, Binghamton, NY 13902, United States of America.
Quinea LassiterSchool of Pharmacy, Department of BioMolecular Sciences, University of Mississippi, MS 38677, United States of America; Department of Microbiology, University of Arizona, Tucson, AZ 85721, United States of America.
Kelsey RaymerSchool of Pharmacy, Department of BioMolecular Sciences, University of Mississippi, MS 38677, United States of America.
Tracy A BrooksSchool of Pharmacy, Department of BioMolecular Sciences, University of Mississippi, MS 38677, United States of America; School of Pharmacy and Pharmaceutical Sciences, Department of Pharmaceutical Sciences, Binghamton University, Binghamton, NY 13902, United States of America. Electronic address: tbrooks@binghamton.edu.
Binghamton University · USUniversity of Arizona · USUniversity of California, Davis · USUniversity of Mississippi · US

Funding

Deconvoluting G-quadruplex and i-Motif dynamics: the role of the physiological stR15CA173667 · NCI · UNIVERSITY OF MISSISSIPPI · PI BROOKS, TRACY ANN, WADKINS, RANDY M · 2013 to 2013
$419k
NCI NIH HHS R15 CA173667
6 · The paper itself

Abstract

Non-B-DNA G-quadruplex (G4) structures have shown promise as molecular targets. Modulating G4 stability for oncogenic transcriptional control is a promising avenue for the development of novel therapeutics. Extracellularly, G4 stabilization can be mediated by alkali cations, modifying water content, or with molecular crowding. Intracellularly, G4 formation is mediated by negative superhelicity and transcriptional activity, and can be stabilized with small molecules or oligonucleotides. Numerous G4-stabilizing compounds have been identified that impact promoter activity in plasmids. These compounds, however, infrequently show activity in cells, are found to have non-G4-mediated mechanisms of action, or do not demonstrate activity in vivo. The G4 field requires enhanced predictive screening methods to identify compounds with G4-mediated in vitro activity and in vivo efficacy. Using the best characterized promoter G4 to date, MYC, we examined the effects of varying annealing conditions (rate of cool down and number of heat/cool cycles), co-solvents (glucose, acetonitrile, polyethylene glycol, dextran sulfate, sucrose, ficoll-70, glycerol) and nucleoplasm on G4 formation and compound screening. We observed a marked decrease in hit rates when shifting from simple buffer conditions to include potassium and glycerol, and utilizing two or more rapid annealing cycles; the difference in hit compounds coincides with previous findings of active, inactive, and non-G4-mediated activity, including NSC338258, Quindoline i, and TMPyP4; with these changes, we describe a modification of the primary FRET Melt screening assay - the FRET Melt

Indexed as

G-QuadruplexesCells, CulturedDrug DiscoveryFluorescence Resonance Energy TransferPromoter Regions, GeneticProto-Oncogene Proteins c-mycSolventsProto-Oncogene Proteins c-mycSolventsFRET meltG-quadruplexMYCPhysiological conditionsSmall molecules

Identifiers

PMID31891781
PMCPMC8922283
OpenAlexW2998614643

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.